Table 5. Demographics and clinical characters of participants in testing phage.
| Health men | IIIA CP/CPPS patients | P value | |||||
|---|---|---|---|---|---|---|---|
| Subgroup | H1 | H2 | H3 | P1 | P2 | P3 | |
| Participants (n) | 12 | 12 | 9 | 10 | 12 | 8 | |
| Total participants (n) | 33 | 30 | |||||
| Age (year) | 31.6 ± 7.4 | 30.2 ± 8.1 | 0.47 | ||||
| Body mass index (kg/m2) | 22.1 ± 1.7 | 21.9 ± 1.5 | |||||
| Employment status | |||||||
| Employed | 8 (24%) | 7 (23%) | 0.93 | ||||
| Unemployed | 25 (76%) | 23 (77%) | |||||
| Marital status | |||||||
| Living with a partner | 8 (24%) | 13 (43%) | 0.11 | ||||
| Single | 25 (76%) | 17 (57%) | |||||
| Sexual activity a | |||||||
| ≤ 2 weekly | 19 (58%) | 17 (57%) | 0.94 | ||||
| ≥3 times weekly | 14 (42%) | 13 (43%) | |||||
| Duration of Pain (month) | 0 | 6.0 ± 2.2 | 0 | ||||
| Total NIH-CPSI score | 4.6 ± 2.3 | 28.9 ± 5.2 | 0 | ||||
| Total pain score | 2.2 ± 1.5 | 16.5 ± 2.7 | 0 | ||||
| Total urination score | 1.1 ± 0.9 | 5.4 ± 2.5 | 0 | ||||
| Quality of life score | 1.3 ± 1.2 | 7.0 ± 2.7 | 0 | ||||
| Pain area | |||||||
| Perineum | 6 (18%) | 25 (83%) | 0.00 | ||||
| Testicles | 4 (12%) | 19 (63%) | 0.00 | ||||
| Penis | 5 (15%) | 20 (67%) | 0.00 | ||||
| Pubic | 5 (15%) | 18 (60%) | 0.00 | ||||
| Pain during urination | 5 (15%) | 20 (67%) | 0.00 | ||||
| Pain during ejaculation | 4 (12%) | 22 (73%) | 0.00 | ||||
| IIEF-5 score b | 21.9 ± 2.6 | 17.8 ± 5.2 | 0.00 | ||||
| Perceived Stress Scale | 13.1 ± 9.2 | 22.5 ± 9.8 | 0.00 | ||||
| Abstinent Days c | 7.2 ± 2.6 | 6.5 ± 2.2 | 0.21 | ||||
| WBC/HP in EPS d | 0 | ||||||
| I grade | 33 (100%) | 0 | |||||
| II grade | 0 | 17 (57%) | |||||
| III grade | 0 | 13 (43%) | |||||
a : Sexual activity in previous 6 months. b : The score of International Index of Erectile Function 5. c : Abstinent days before EPS collection. d : WBC count in EPS was classified into three grades: I grade: < 10/high power field (HP), II grade: 10∼20/HP, III grade: > 20/HP.